- Home
- Industry Solutions
- Services
- Support
- About Us
Using animal models in pharmaceutical research is based on the notion that basic biological processes are sufficiently similar across species so that they can be extrapolated to humans.
Through the development and utilization of animal models, scientists have been able to make significant strides in improving the health and well-being of both humans and animals, leading to numerous medical breakthroughs and advancements. Animal models that can be used to test drug in vivo are crucial for studying the absorption, distribution, metabolism, and excretion (ADME) of drugs. They are also useful to provide information on toxicity, adverse effects, and drug-drug interactions to ensure the safety of a drug before it enters clinical trials.
The selection of animal models can vary depending on the research objectives, with options including homozygous animals, isomorphic animals, and predictive models. Animal models that accurately mimic the disease pathophysiology are extremely useful in characterizing the mechanism of action, pharmacokinetics, pharmacodynamics, toxicity, and efficacy of potential therapies, as well as for human dose prediction in clinical trials. In drug testing, both invertebrate and vertebrate models are utilized. Invertebrate animal models such as zebrafish are commonly used for drug studies involving genetic, neurological, and developmental disorders. Vertebrate models such as mice and rats are important for translational research. The biochemical and physiological similarities between animal models and humans as well as the underlying mechanisms of ADME properties of drugs in the animal are important considerations in the selection of species.
Fig.1 Some animal species have been ingrained as models for specific diseases and areas of study. (Brake, 2017)
The similarities of disease symptoms and/or disease aetiology in humans and animals is the basis for the development of animal models. A valid animal model is one that closely resembles the human condition in terms of pathogenesis, pathophysiology, symptoms, and response to therapeutic interventions. This validity is typically assessed through three aspects including predictive validity, face validity, and construct validity.
With expertise in each step of drug discovery and development, combined with a precise and meticulous work ethic, Creative Biolabs is capable of maintaining complete control over all critical the steps and developing effective, high-quality drug solutions. If you are interested in our services, please feel free to contact us for more.
Reference